Developer docs
API playgroundTry for free, no card

Search company profiles

FIGUR8

Full company profile

uuid000051e

Namestring
FIGUR8
Legal namestring
FIGUR8 Inc
Websiteurl
figur8tech.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

FIGUR8 is a Boston-based health technology company that develops and commercializes the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor system combining inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to capture lab-grade biomechanics data during dynamic movement. Founded in 2019 as a spinout from MIT Media Lab, Massachusetts General Hospital Orthopaedics, and the Boston Red Sox, the company targets the musculoskeletal (MSK) care market by replacing subjective clinical assessments with objective biomarker data on joint motion and muscle function. Its platform captures over one million data points per assessment, against roughly six points in conventional tools, and feeds AI-driven features including the MovementMemo generative AI documentation tool and the Recovery Indicator recovery-intelligence module.

The company sells through a tiered channel-partner program organized into Local, Regional, and National tiers covering physical therapy clinic networks such as Physical Rehabilitation Network, CORA Physical Therapy, Team Rehab, and Upstream Rehabilitation, supplemented by direct enterprise sales to payers, self-insured employers, and workers' compensation organizations. Revenue derives from clinic subscriptions and per-assessment usage of the platform, hardware sales of the sensor device kits, and professional services including onboarding and training. The American Medical Association issued a technology-specific Category III CPT code for the IMU + sMMG sensor fusion system, establishing a reimbursement pathway and supporting ROI claims of a 4:1 clinic return and a 5:1 payer return alongside a reported 22% faster recovery rate for FIGUR8-enabled practices.

FIGUR8 raised approximately $44.5 million in venture funding across a 2019 seed, a 2021 Series A led by Taiwania Capital, and a 2023 Series A-1 led by First Spark Ventures. In 2025 the company launched MovementMemo and Recovery Indicator, expanded into employer and orthopedic telehealth channels through partnerships with Parker Hannifin and Best In Class MD, and appointed a new COO. In 2026 the company was acquired by Myant, integrating FIGUR8 into a larger connected-health platform.

Short descriptiontext

FIGUR8 is a Boston-based health technology company offering an FDA-registered wearable sensor platform that combines IMU and proprietary Surface Mechanomyography to deliver objective musculoskeletal assessments for physical therapy providers, payers, employers, and patients.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
musculoskeletal health assessment, wearable sensor technology, biomechanics data analytics, physical therapy solutions, workers compensation analytics
Industry3 codes
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Musculoskeletal Health Assessment Technology
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Assessment Platform/Subscription
TypeSubscription Recurring
Description

FIGUR8 enables clinics to use the bioMotion Assessment Platform for patient assessments. Revenue generated through clinic subscriptions and per-assessment usage. ROI calculator shows revenue opportunity per clinic based on payer mix.

figur8tech.com
2Wearable Hardware
TypeHardware Sales
Description

Proprietary wearable sensor devices (device tray with sensors) used for assessments. Hardware components required for data collection during bioMotion assessments.

figur8tech.com
3Professional Services & Training
TypeProfessional Services
Description

Training, onboarding, and support services for FIGUR8-enabled providers including video training resources, support materials, dedicated provider success manager, and live in-person onboarding for qualifying providers.

figur8tech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations
Pricing details1 tier
1ROI Calculator shows potential revenue opportunity for clinics
ModelOtherBilling cadenceAnnual
Notes

The ROI calculator projects annual gross revenue opportunity based on payer mix (Workers Comp, Medicare, Medicaid, Commercial Health, Cash Pay) and visits per day. Sample calculation shows $87,300 annual gross revenue opportunity for a single clinic.

figur8tech.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

FIGUR8 develops and sells the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor-based system that combines inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to deliver objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. The platform includes AI-powered tools (MovementMemo, Recovery Indicator) and is offered to physical therapy providers, payers, and employers alongside proprietary wearable sensor hardware and training services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 22% faster recovery rates for FIGUR8-enabled clinical practices
+3 more records
Product overview1 text field

FIGUR8 is a health technology company offering the FDA-registered bioMotion Assessment Platform (bMAP) — a comprehensive wearable sensor and cloud analytics system for objective musculoskeletal (MSK) health assessment. The platform combines proprietary Surface Mechanomyography (sMMG) sensors with inertial measurement units (IMU) to capture lab-grade biomechanics data during movement assessments. The core offering is supplemented by MovementMemo (a generative AI tool for automated patient progress documentation), the Recovery Indicator (AI-driven recovery intelligence), and specialized solutions for healthcare providers, payers, and patients. The platform received a Category III CPT code from the American Medical Association, enabling reimbursement for the MSK assessment technology.

Product and service2 records
1bioMotion Assessment Platform (bMAP)
CategoryMusculoskeletal Assessment Platform
Description

FDA-registered wearable sensor platform combining IMU and Surface Mechanomyography (sMMG) sensors to provide objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. Used by physical therapy providers, payers, employers, and orthopedic specialists.

2Device Tray (Assessment Device Kit)
CategoryWearable Hardware
Description

Proprietary hardware kit containing all sensors and devices required to perform bioMotion assessments, used for storage and charging between sessions. Sold to provider and employer customers alongside the bMAP platform.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-07-16
Description

FIGUR8 selected as spoke member of nationwide network working to accelerate transformative health solutions through collaboration with innovators.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-04-11
Description

Partnership with leading orthopedic telehealth platform to combine precision MSK analytics with world-class orthopedic care. First offering combining MSK sensor technology with top orthopedic physician access.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-03-01
Description

Fortune 250 global leader in motion and control technologies partnered for deployment of FIGUR8's MSK health technology in select Parker manufacturing facilities. Focus on workplace MSK health and injury prevention.

4Toppan
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-10-08
Description

Pilot test for online fitness instruction using musculoskeletal sensors, enabling personalized training for functional improvement based on objective quantitative data.

figur8tech.com
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

National PT network partner surpassing 10,000 patient assessments using FIGUR8's bMAP. FIGUR8 provides training, onsite training, and continued support for PRN care providers.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

National PT provider network using FIGUR8 technology for objective MSK assessments across their clinic network.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Physical therapy provider partner implementing FIGUR8 assessments for injured workers including work-related motor vehicle accidents.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Largest outpatient physical therapy provider partnering with FIGUR8 for technology evaluation and utilization in patient care.

Strategic tierCoreTypeGTM or Marketing Partner
Description

FIGUR8 signed APTA Digital Transparency pledge. Active participation in APTA conferences and events. FIGUR8 contributes to MSK data standards discussions within PT profession.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

FIGUR8 originated as collaboration between MIT scientists, Massachusetts General Hospital Orthopaedics, and Boston Red Sox. MIT Media Lab spinout with founding technology from MIT research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration partner in original founding of FIGUR8. Research collaboration for MSK diagnostic technology development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Original founding collaboration for MSK health technology development. Boston Red Sox Sports Science Lab contributed to biomechanics research that led to FIGUR8 technology.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Markerless, camera-based motion-capture system providing objective MSK and biomechanical assessment for physical therapy, sports performance, and occupational health — directly comparable to FIGUR8 in clinical use case and target buyer.

TypeDirect peer
Description

Provides quantitative functional capacity and movement assessment tools used by physical therapy providers, employers, and payers for MSK evaluation and return-to-work decisions.

3Physimax
TypeDirect peer
Description

AI-driven markerless motion analysis platform for MSK injury risk screening, rehabilitation tracking, and orthopedic assessment — overlaps with FIGUR8 on objective biomechanics and PT/sports medicine customers.

TypeDirect peer
Description

Offers force-plate and motion-capture systems widely used by physical therapists and sports organizations to quantify strength, balance, and movement — a comparable objective-assessment vendor to FIGUR8 in rehab and sports settings.

5Biodex Medical Systems
TypeDirect peer
Description

Manufactures clinical rehabilitation and MSK evaluation equipment used in physical therapy clinics and hospitals, addressing similar objective-assessment and rehabilitation use cases as FIGUR8.

TypeBroad incumbent
Description

Large-scale digital MSK care platform combining wearable sensors, exercise therapy, and coaching for employers and payers. A broader incumbent that competes with FIGUR8 for payer and employer MSK budgets even though its care model differs.

TypeBroad incumbent
Description

Digital MSK and chronic pain platform used by employers and health plans, providing an adjacent solution in the value-based MSK care market where FIGUR8 sells to payers and employers.

8Sword Health
TypeBroad incumbent
Description

Virtual MSK care provider combining digital exercise therapy with human clinicians for employers and health plans — competes for the same payer and employer budgets and overlaps with FIGUR8's objective-assessment narrative.

TypeDirect peer
Description

Provider of clinical-grade gait, motion-analysis, and surface EMG/EMG systems for rehabilitation and biomechanics research — a longstanding player in the same objective MSK and rehabilitation-assessment category as FIGUR8.

TypeDirect peer
Description

Medical device company combining wearable EMG-driven orthotics with software for MSK and neurological rehabilitation — overlaps with FIGUR8 on wearable MSK sensors and rehab-provider customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FIGUR8

Musculoskeletal Health Assessment Technologyfigur8tech.com

FIGUR8 is a Boston-based health technology company offering an FDA-registered wearable sensor platform that combines IMU and proprietary Surface Mechanomyography to deliver objective musculoskeletal assessments for physical therapy providers, payers, employers, and patients.

What FIGUR8 does

FIGUR8 is a Boston-based health technology company that develops and commercializes the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor system combining inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to capture lab-grade biomechanics data during dynamic movement. Founded in 2019 as a spinout from MIT Media Lab, Massachusetts General Hospital Orthopaedics, and the Boston Red Sox, the company targets the musculoskeletal (MSK) care market by replacing subjective clinical assessments with objective biomarker data on joint motion and muscle function. Its platform captures over one million data points per assessment, against roughly six points in conventional tools, and feeds AI-driven features including the MovementMemo generative AI documentation tool and the Recovery Indicator recovery-intelligence module.

The company sells through a tiered channel-partner program organized into Local, Regional, and National tiers covering physical therapy clinic networks such as Physical Rehabilitation Network, CORA Physical Therapy, Team Rehab, and Upstream Rehabilitation, supplemented by direct enterprise sales to payers, self-insured employers, and workers' compensation organizations. Revenue derives from clinic subscriptions and per-assessment usage of the platform, hardware sales of the sensor device kits, and professional services including onboarding and training. The American Medical Association issued a technology-specific Category III CPT code for the IMU + sMMG sensor fusion system, establishing a reimbursement pathway and supporting ROI claims of a 4:1 clinic return and a 5:1 payer return alongside a reported 22% faster recovery rate for FIGUR8-enabled practices.

FIGUR8 raised approximately $44.5 million in venture funding across a 2019 seed, a 2021 Series A led by Taiwania Capital, and a 2023 Series A-1 led by First Spark Ventures. In 2025 the company launched MovementMemo and Recovery Indicator, expanded into employer and orthopedic telehealth channels through partnerships with Parker Hannifin and Best In Class MD, and appointed a new COO. In 2026 the company was acquired by Myant, integrating FIGUR8 into a larger connected-health platform.

FIGUR8 firmographics

Firmographics
Name
FIGUR8
Legal name
FIGUR8 Inc
Website
https://figur8tech.com
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
11–50 employees
Short description
FIGUR8 is a Boston-based health technology company offering an FDA-registered wearable sensor platform that combines IMU and proprietary Surface Mechanomyography to deliver objective musculoskeletal assessments for physical therapy providers, payers, employers, and patients.
Ownership category
akta.pro rank

FIGUR8 industry classification

Industry
Product category
Musculoskeletal Health Assessment Technology
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Musculoskeletal health assessment
  • Wearable sensor technology
  • Biomechanics data analytics
  • Physical therapy solutions
  • Workers compensation analytics

Where FIGUR8 is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

FIGUR8 business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Assessment Platform/Subscription: FIGUR8 enables clinics to use the bioMotion Assessment Platform for patient assessments. Revenue generated through clinic subscriptions and per-assessment usage. ROI calculator shows revenue opportunity per clinic based on payer mix.
  2. Wearable Hardware: Proprietary wearable sensor devices (device tray with sensors) used for assessments. Hardware components required for data collection during bioMotion assessments.
  3. Professional Services & Training: Training, onboarding, and support services for FIGUR8-enabled providers including video training resources, support materials, dedicated provider success manager, and live in-person onboarding for qualifying providers.

Pricing tiers

ModelBillingPrice
OtherAnnualROI Calculator shows potential revenue opportunity for clinics

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

FIGUR8 product offering

Product offering

Core offering

FIGUR8 develops and sells the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor-based system that combines inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to deliver objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. The platform includes AI-powered tools (MovementMemo, Recovery Indicator) and is offered to physical therapy providers, payers, and employers alongside proprietary wearable sensor hardware and training services.

Product overview

FIGUR8 is a health technology company offering the FDA-registered bioMotion Assessment Platform (bMAP) — a comprehensive wearable sensor and cloud analytics system for objective musculoskeletal (MSK) health assessment. The platform combines proprietary Surface Mechanomyography (sMMG) sensors with inertial measurement units (IMU) to capture lab-grade biomechanics data during movement assessments. The core offering is supplemented by MovementMemo (a generative AI tool for automated patient progress documentation), the Recovery Indicator (AI-driven recovery intelligence), and specialized solutions for healthcare providers, payers, and patients. The platform received a Category III CPT code from the American Medical Association, enabling reimbursement for the MSK assessment technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • bioMotion Assessment Platform (bMAP) FDA-registered wearable sensor platform combining IMU and Surface Mechanomyography (sMMG) sensors to provide objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. Used by physical therapy providers, payers, employers, and orthopedic specialists.
  • Device Tray (Assessment Device Kit) Proprietary hardware kit containing all sensors and devices required to perform bioMotion assessments, used for storage and charging between sessions. Sold to provider and employer customers alongside the bMAP platform.

Quantifiable outcome

  • 22% faster recovery rates for FIGUR8-enabled clinical practices
  • +3 more outcomes

Companies that use FIGUR8

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

FIGUR8 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

FIGUR8 partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered minor, major and core.

  • ARPA-H Investor Catalyst HubminorGTM or Marketing Partner · 16 July 2024FIGUR8 selected as spoke member of nationwide network working to accelerate transformative health solutions through collaboration with innovators.
  • Best In Class MDmajorStrategic or Co-development Partner · 11 April 2022Partnership with leading orthopedic telehealth platform to combine precision MSK analytics with world-class orthopedic care. First offering combining MSK sensor technology with top orthopedic physician access.
  • Parker Hannifin Quick Coupling DivisionmajorStrategic or Co-development Partner · 1 March 2022Fortune 250 global leader in motion and control technologies partnered for deployment of FIGUR8's MSK health technology in select Parker manufacturing facilities. Focus on workplace MSK health and injury prevention.
  • ToppanminorStrategic or Co-development Partner · 8 October 2020Pilot test for online fitness instruction using musculoskeletal sensors, enabling personalized training for functional improvement based on objective quantitative data.
  • Physical Rehabilitation Network (PRN)majorChannel Partner/ Reseller/ DistributorNational PT network partner surpassing 10,000 patient assessments using FIGUR8's bMAP. FIGUR8 provides training, onsite training, and continued support for PRN care providers.
  • CORA Physical TherapymajorChannel Partner/ Reseller/ DistributorNational PT provider network using FIGUR8 technology for objective MSK assessments across their clinic network.
  • Team RehabmajorChannel Partner/ Reseller/ DistributorPhysical therapy provider partner implementing FIGUR8 assessments for injured workers including work-related motor vehicle accidents.
  • Upstream RehabilitationmajorChannel Partner/ Reseller/ DistributorLargest outpatient physical therapy provider partnering with FIGUR8 for technology evaluation and utilization in patient care.
  • American Physical Therapy Association (APTA)coreGTM or Marketing PartnerFIGUR8 signed APTA Digital Transparency pledge. Active participation in APTA conferences and events. FIGUR8 contributes to MSK data standards discussions within PT profession.
  • MIT (Massachusetts Institute of Technology)coreStrategic or Co-development PartnerFIGUR8 originated as collaboration between MIT scientists, Massachusetts General Hospital Orthopaedics, and Boston Red Sox. MIT Media Lab spinout with founding technology from MIT research.
  • Massachusetts General Hospital OrthopaedicscoreStrategic or Co-development PartnerClinical collaboration partner in original founding of FIGUR8. Research collaboration for MSK diagnostic technology development.
  • Boston Red SoxcoreStrategic or Co-development PartnerOriginal founding collaboration for MSK health technology development. Boston Red Sox Sports Science Lab contributed to biomechanics research that led to FIGUR8 technology.

Scale indicators6 records

Recent moves8 records

Expansion highlights7 records

FIGUR8 competitors and assessment

Company assessment

Direct peers

  • DARI Motion: Markerless, camera-based motion-capture system providing objective MSK and biomechanical assessment for physical therapy, sports performance, and occupational health — directly comparable to FIGUR8 in clinical use case and target buyer.
  • Kinesis QT9: Provides quantitative functional capacity and movement assessment tools used by physical therapy providers, employers, and payers for MSK evaluation and return-to-work decisions.
  • Physimax: AI-driven markerless motion analysis platform for MSK injury risk screening, rehabilitation tracking, and orthopedic assessment — overlaps with FIGUR8 on objective biomechanics and PT/sports medicine customers.
  • Vald Health (ForceDecks / NordBord / HumanTrak): Offers force-plate and motion-capture systems widely used by physical therapists and sports organizations to quantify strength, balance, and movement — a comparable objective-assessment vendor to FIGUR8 in rehab and sports settings.
  • Biodex Medical Systems: Manufactures clinical rehabilitation and MSK evaluation equipment used in physical therapy clinics and hospitals, addressing similar objective-assessment and rehabilitation use cases as FIGUR8.
  • BTS Bioengineering: Provider of clinical-grade gait, motion-analysis, and surface EMG/EMG systems for rehabilitation and biomechanics research — a longstanding player in the same objective MSK and rehabilitation-assessment category as FIGUR8.
  • Myomo: Medical device company combining wearable EMG-driven orthotics with software for MSK and neurological rehabilitation — overlaps with FIGUR8 on wearable MSK sensors and rehab-provider customers.

Broad incumbents

  • Hinge Health: Large-scale digital MSK care platform combining wearable sensors, exercise therapy, and coaching for employers and payers. A broader incumbent that competes with FIGUR8 for payer and employer MSK budgets even though its care model differs.
  • Kaia Health: Digital MSK and chronic pain platform used by employers and health plans, providing an adjacent solution in the value-based MSK care market where FIGUR8 sells to payers and employers.
  • Sword Health: Virtual MSK care provider combining digital exercise therapy with human clinicians for employers and health plans — competes for the same payer and employer budgets and overlaps with FIGUR8's objective-assessment narrative.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

FIGUR8 social profiles

Digital presence

FIGUR8 compliance and trust

Trust signal

Compliance5 records

FIGUR8 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FIGUR8 leadership team

Management profile

Number of profiles

Profiles11 records

FIGUR8 funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FIGUR8 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FIGUR8

What does FIGUR8 do?

FIGUR8 develops and sells the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor-based system that combines inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to deliver objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. The platform includes AI-powered tools (MovementMemo, Recovery Indicator) and is offered to physical therapy providers, payers, and employers alongside proprietary wearable sensor hardware and training services.

Is FIGUR8 a public or private company?

FIGUR8 is a private company. It is classified as corporate owned and is currently acquired.

When was FIGUR8 founded?

FIGUR8 was founded in 2019. It employs 11 to 50 people.

Where is FIGUR8 based?

FIGUR8 is headquartered in Boston, United States, in the North America region.

How does FIGUR8 make money?

Three revenue lines are on record. Assessment Platform/Subscription is the primary driver. The others are wearable Hardware and professional Services & Training.

Who are FIGUR8's main competitors?

Direct peers on record are DARI Motion, Kinesis QT9, Physimax, Vald Health (ForceDecks / NordBord / HumanTrak), Biodex Medical Systems, BTS Bioengineering and Myomo. Broad incumbents are Hinge Health, Kaia Health and Sword Health.

Does FIGUR8 have an API?

No public API is recorded for FIGUR8.

What industry is FIGUR8 in?

FIGUR8's product category is Musculoskeletal Health Assessment Technology. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Inc.Her Healthcare Startup’s Tech Worked Perfectly. But She Had to Learn a Brutal Lesson to Actually Scale ItFIGUR8 founder Nan-Wei Gong built technology to bring quantitative, data-driven measurement to musculoskeletal healthcare, addressing the gap between elite athletes' access to sophisticated tools and everyday patients relying on subjective clinical assessments. Despite compelling clinical results and securing a new CPT code, the company faced years of slow healthcare adoption due to complex workflows, reimbursement challenges, and the need to demonstrate measurable value to multiple stakeholders before being acquired by Myant. Gong's key learning was that healthcare success requires building trust incrementally through evidence and clinical champions rather than aggressive sales tactics.The National Law ReviewMyant Acquires Boston-Based FIGUR8 to Enhance Its Internet of HumMyant acquired Boston-based FIGUR8, a venture-backed MIT spinout, to add musculoskeletal assessment to its SKIIN textile computing platform. FIGUR8's wearable sensors and AI analytics quantify injury severity and track recovery, while Myant's SKIIN provides at-home cardiometabolic monitoring. The combined platform aims to bridge clinical and home care for continuous, preventative health models.EIN PresswireMyant Acquires Boston-Based FIGUR8 to Enhance Its Internet of Humans Platform With Musculoskeletal IntelligenceMyant acquired Boston-based FIGUR8, a venture-backed MIT spinoff, to integrate musculoskeletal intelligence into its textile computing platform. FIGUR8's wearable sensors and AI analytics quantify injury severity and track recovery, complementing Myant's SKIIN cardiometabolic monitoring. The combined platform aims to bridge clinical and home care, improving outcomes and enabling preventative models.Figur8TechFIGUR8FIGUR8 has introduced a Recovery Indicator aimed at enhancing rehabilitation through precise musculoskeletal assessments. The technology, which is the first FDA-registered MSK assessment of its kind, aims to improve recovery outcomes and drive efficient claims management in healthcare. FIGUR8's innovative platform is expected to significantly impact the workers' compensation sector over the next five years.Pulse 2.0FIGUR8 To Advance bioMotion Assessment Platform With New Funding RoundFIGUR8 has closed a $25 million Series A-1 funding round, led by First Spark Ventures with participation from DigiTx Partners and Phoenix Venture Partners. The funding will be used to expand the adoption of its bioMotion Assessment Platform, aimed at enhancing musculoskeletal health and injury recovery through data-driven insights. This investment is expected to elevate standards in the musculoskeletal industry and promote advancements in digital health solutions.VC News DailyFIGUR8 Secures $25M Series A-1 FinancingFIGUR8, a company focused on musculoskeletal health measurement, has closed a $25 million Series A-1 financing round. The investment was led by First Spark Ventures and included participation from DigiTx Partners and Phoenix Venture Partners.Sports Business JournalWearable biomechanics analysis company FIGUR8 secures $25 millionFIGUR8, a wearable biomechanics analysis company spun out of the MIT Media Lab, has closed a $25 million Series A-1 round led by First Spark Ventures, with DigiTx Partners and Phoenix Venture Partners joining. The company had raised over $15 million before this round and offers musculoskeletal insights through its bioMotion Assessment Platform.FinSMEsFigur8 Raises $25M in Series A-1 FinancingFigur8, a Boston-based company specializing in musculoskeletal health, has closed a $25 million Series A-1 funding round led by First Spark Ventures, with participation from DigiTx Partners and Phoenix Venture Partners. The funds will be utilized to enhance the growth and adoption of its bioMotion Assessment Platform (bMAP). Figur8 aims to standardize musculoskeletal health and improve the recovery process through advanced data analytics for patients and providers.Venture Capital Access OnlineFIGUR8, the market leader for measuring musculoskeletal (MSK) health and injury recovery, secures $25M Series A-1 financingFIGUR8, a provider of musculoskeletal health assessment technology, closed a $25 million Series A-1 funding round led by First Spark Ventures with participation from DigiTx Partners and Phoenix Venture Partners. The company intends to use the capital to drive growth and adoption of its bioMotion Assessment Platform (bMAP).Business Wire BlogFIGUR8, the market leader for measuring musculoskeletal (MSK) health and injury recovery, secures $25M Series A-1 financingFIGUR8 has closed a $25 million Series A-1 funding round led by First Spark Ventures, with participation from DigiTx Partners and Phoenix Venture Partners. The company intends to use the capital to drive growth and adoption of its bioMotion Assessment Platform (bMAP), which provides objective biomechanical data for musculoskeletal health and injury recovery.